We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva Trying to Divest Products Ahead of Allergan Deal
Teva Trying to Divest Products Ahead of Allergan Deal
Teva Pharmaceuticals is getting ready to divest assets in anticipation of regulatory objections to its purchase of Allergan’s generics division, according to a corporate filing.